check_circleStudy Completed
Atrial Fibrillation
Bayer Identifier:
20104
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Treatment Pattern of NOACs (non-vitamin K oral anticoagulants) in Outpatient Users in Colombian Databases
Trial purpose
This population-based descriptive study will characterize first-time users of three NOACs (rivaroxaban, dabigatran and apixaban) in prevention of stroke in non-valvular atrial fibrillation (SPAF) patients and will assess the patterns of drug utilization in routine general practice in Colombia
Key Participants Requirements
Sex
AllAge
18 - N/ATrial summary
Enrollment Goal 
10528Trial Dates 
February 2018 - July 2018Phase 
Phase 4Could I Receive a placebo 
NoProducts 
Xarelto (Rivaroxaban, BAY59-7939)Accepts Healthy Volunteer 
NoWhere to participate
| Status | Institution | Location | 
|---|---|---|
| Completed | Many Locations | Many Locations, Colombia | 
Primary Outcome
- Agedate_rangeTime Frame:At Baseline
- Sexdate_rangeTime Frame:At Baseline
- Co-morbiditydate_rangeTime Frame:At Baseline
- Healthcare utilizationPrimary Care Physicians visits, Outpatient visits and Hospital admissionsdate_rangeTime Frame:Up to 2 years
- Proportion of Naive to non-naive patientdate_rangeTime Frame:At Baseline
- Dose at first prescriptiondate_rangeTime Frame:Up to 6 years
- Duration of treatmentdate_rangeTime Frame:Up to 6 years
- Discontinuationdate_rangeTime Frame:Up to 6 years
- Switch to another study drugdate_rangeTime Frame:Up to 6 years
Secondary Outcome
- Time trends of usage of study medicationsdate_rangeTime Frame:Up to 6 years
Trial design
Trial Type 
ObservationalIntervention Type 
OtherTrial Purpose 
N/AAllocation 
N/ABlinding 
N/AAssignment 
N/ATrial Arms 
N/A